A clinically relevant reinterpretation of disk approximation testing for inducible AmpC in Pseudomonas aeruginosa
Revista Española de Quimioterapia · 2025
DOI: 10.37201/req/089.2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Española de Quimioterapia, 2025. Verfasst von Arturo Reyes-Gualito und 5 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology Laboratory, Clinical Analysis of León, HRAEB Unit, León, Guanajuato, México. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Ceftazidime, Anti-Bacterial Agents, beta-Lactamases. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Current antimicrobial susceptibility methods fail to capture the variability of AmpC induction pathways in Pseudomonas aeruginosa. This leads to preventable errors in ceftazidime susceptibility reporting. We introduce a reinterpretation for the disk approximation test, based on the categorical change in ceftazidime susceptibility upon imipenem exposure. Materials and methods: A total of 73 ceftazidime-susceptible P. aeruginosa isolates were evaluated. Automated broth microdilution test was the reference standard. AmpC inducibility was conventionally defined as a ≥5 mm flattening of the ceftazidime inhibition zone adjacent to imipenem. Our novel criterion for inducibility was a change in ceftazidime category from susceptible to nonsusceptible. The probability of error in ceftazidime reporting was evaluated with three parameters. ROC curve, comparative and regression analyses were performed.
Results
The reference method showed an overall error probability of 35.6%. The conventional 5 mm cutoff interpretation reduced this rate to 5.4%, but generated a significant proportion of false positives and negatives. Regression analyses showed that the flattening effect is a strong predictor of the categorical change. No association was found between basal ceftazidime susceptibility and AmpC inducibility.
Conclusion
Our reinterpretation criterion for disk approximation test turns a phenotypic assay into a clinically relevant diagnostic tool to avoid errors in ceftazidime susceptibility reports. Moreover, this interpretation is readily applicable in routine microbiology laboratories, and has the potential to be directly useful for antimicrobial stewardship efforts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Microbiology Laboratory, Clinical Analysis of León, HRAEB Unit, León, Guanajuato, México.
- Department of Medicine and Nutrition, University of Guanajuato, León, Guanajuato, México.
- Research Department, High Specialty Regional Hospital at El Bajío, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-Bienestar), León, Guanajuato, México. jalvarez.hraeb@imssbienestar.g…
ORCID-Profile: Arturo Reyes-Gualito, María José Orozco-Uriarte, Alejandro E Macías, José Antonio Álvarez-Canales
Zitieren
APA
Reyes-Gualito, A., Rivera-Garay, L. R., Cobo-Alva, A., Orozco-Uriarte, M. J., Macías, A. E., & Álvarez-Canales, J. A. (2025). A clinically relevant reinterpretation of disk approximation testing for inducible AmpC in Pseudomonas aeruginosa. Revista Española de Quimioterapia. https://doi.org/10.37201/req/089.2025
Vancouver
Reyes-Gualito A, Rivera-Garay LR, Cobo-Alva A, Orozco-Uriarte MJ, Macías AE, Álvarez-Canales JA. A clinically relevant reinterpretation of disk approximation testing for inducible AmpC in Pseudomonas aeruginosa. Revista Española de Quimioterapia. 2025. doi:10.37201/req/089.2025
BibTeX
@article{ReyesGualito2025,
author = {Reyes-Gualito, Arturo and Rivera-Garay, Luis Raúl and Cobo-Alva, Azyadeh and Orozco-Uriarte, María José and Macías, Alejandro E and Álvarez-Canales, José Antonio},
title = {A clinically relevant reinterpretation of disk approximation testing for inducible AmpC in Pseudomonas aeruginosa},
journal = {Revista Española de Quimioterapia},
year = {2025},
doi = {10.37201/req/089.2025}
}
EUVIMED